5 Biotech Penny Stocks Redditors Love
In this article, we discuss 5 biotech penny stocks that Redditors love.
Posts Tagged ‘NASDAQ:PSTI’
10 Biotech Penny Stocks with Growth Catalysts
In this article, we discuss 10 biotech penny stocks with growth catalysts.
15 Worst Stock Picks of Cathie Wood
In this article, we discuss the 15 worst stock picks of Cathie Wood.
Cathie Wood is Getting Rid of These 10 Stocks
In this article, we discuss the 10 stocks Cathie Wood is getting rid of.
Where Do Hedge Funds Stand On Pluristem Therapeutics Inc. (PSTI)?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change...
Hedge Funds Nibbling On Pluristem Therapeutics Inc. (PSTI)
In this article we will take a look at whether hedge funds think Pluristem Therapeutics Inc. (NASDAQ:PSTI) is a good investment right now.
Hedge Funds Have Never Been More Bullish On Pluristem Therapeutics Inc. (PSTI)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Fund and Insider Trading News: Daniel Loeb, Starboard Value LP, Sachem Head Capital Management, Pluristem Therapeutics Inc. (PSTI), Tradeweb Markets Inc (TW), and More
Shares of health care technology provider Cerner (CERN) jumped Tuesday after the company said it had reached an agreement with activist hedge fund Starboard Value LP to appoint...
Hedge Fund and Insider Trading News: Larry Robbins, Point72 Asset Management, NII Holdings (NIHD), Marchex, Inc. (MCHX), Corvus Pharmaceuticals Inc (CRVS), and More
Larry Robbins is a hedge fund manager and CEO of Glenview Capital Management. He is also well known for his quarterly letters to investors.
Pluristem Therapeutics Inc. (PSTI) To Begin CLI Phase III Trial Enrolling Only 250 Patients, With FDA Blessing
If we could point to one thing that keeps Big Pharma on top and smaller pharmaceutical companies dependent, it’s the exorbitant costs of phase III trials.
Why Pluristem Therapeutics Inc. (PSTI) Is So Undervalued – The Market Is Ignoring Manufacturing
The entirety of the long investment game comes down to being able to accurately spot the undervalued. Undervaluation exists for many reasons.
Pluristem Therapeutics Inc. (PSTI) Gears Up For Critical Blood Stem Cell Trial
Investors who play the developing biotech niche are always on the lookout for shortcuts to approval. A shortcut can come in two ways.
Will Pluristem Therapeutics Inc. (PSTI) Succeed in CLI Where Sanofi SA (ADR) (SNY) Failed?
It’s every junior biotech company’s dream to be accepted into an accelerated approval pathway for a potentially blockbuster drug. Very few achieve it.
Here’s A Look At Two Promising CLI Companies And Their Near Term Milestones – Pluristem Therapeutics Inc. (PSTI) Cesca Therapeutics Inc (KOOL)
Stem cell therapy is one of the most exciting areas of development stage healthcare right now, and it’s being put to the test in a wide range of potential therapeutic areas.
Japan is Breathing Life into the Stem Cell Space, Astellas Pharma (ALPMF) & Pluristem Therapeutics Inc. (PSTI) Are Benefiting
Japan is the stem cell capital of the world.
Why AMC Entertainment, Winnebago Industries and Three Other Stocks Are Trending Today
Some stocks are in the spotlight today, including Gol Linhas Aereas Inteligentes SA (ADR) (NYSE:GOL), Winnebago Industries, Inc. (NYSE:WGO), Pluristem Therapeutics Inc.
